3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
5
Active not recruiting
2
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
10
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Recurrence
2
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Adenocarcinoma
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Non-small Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
HER2-positive Breast Cancer
1
Gastroesophageal Junction Cancer
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Advanced Solid Tumors
1
Advanced Pancreatic Cancer
1
Advanced Non-small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
Advanced Malignant Neoplasm
1
Advanced Esophageal Carcinoma
1
Advanced Breast Cancer
1
Interventions
Gemcitabine
6
Radiotherapy
4
Mitomycin
3
Epirubicin
2
toripalimab
1
tislelizumab
1
pirarubicin
1
hydroxycamptothecinum
1
Watchful Waiting
1
Maintenance
1
Injections
1
Docetaxel
1
BCG Vaccine
1
Anesthesia, Spinal
1
Anesthesia, General
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Non-Muscle Invasive Bladder Neoplasms
×
Docetaxel
×
Clear all
NCT06227065
2024-01-26
POLO
University of Bern
Phase 2
Not yet recruiting
28 enrolled